60 years of metformin use: a glance at the past and a look to the future Sally M. Marshall Editorial 03 August 2017 Pages: 1561 - 1565
The mechanisms of action of metformin Graham RenaD. Grahame HardieEwan R. Pearson Review Open access 03 August 2017 Pages: 1577 - 1585
Metformin: clinical use in type 2 diabetes Elizabeth Sanchez-RangelSilvio E. Inzucchi Review 02 August 2017 Pages: 1586 - 1593
A new perspective on metformin therapy in type 1 diabetes Rachel LivingstoneJames G. Boyleon behalf of The REMOVAL Study Team Review Open access 02 August 2017 Pages: 1594 - 1600
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study Vanita R. ArodaWilliam C. Knowlerfor the Diabetes Prevention Program Research Group Review 02 August 2017 Pages: 1601 - 1611
Metformin use in pregnancy: promises and uncertainties Robert S. LindsayMary R. Loeken Review Open access 02 August 2017 Pages: 1612 - 1619
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes Simon J. GriffinJames K. LeaverGreg J. Irving Review Open access 02 August 2017 Pages: 1620 - 1629
Metformin and ageing: improving ageing outcomes beyond glycaemic control Willy Marcos ValenciaAna PalacioHermes Florez Review 02 August 2017 Pages: 1630 - 1638
Repurposing metformin for the prevention of cancer and cancer recurrence Brandy M. Heckman-StoddardAndrea DeCensiLeslie G. Ford Review 03 August 2017 Pages: 1639 - 1647
Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome Susan SamDavid A. Ehrmann Review 03 August 2017 Pages: 1656 - 1661
The effects of metformin on gut microbiota and the immune system as research frontiers Michael Pollak Review 02 August 2017 Pages: 1662 - 1667
Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study Helen R. MurphyRuth BellNick Lewis-Barned Article Open access 08 June 2017 Pages: 1668 - 1677
Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case–control study Christoffer PolcwiartekKristian KragholmJimmi Nielsen Article 07 June 2017 Pages: 1678 - 1690
Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study Anna ButMarie L. De BruinJari Haukka Article Open access 01 June 2017 Pages: 1691 - 1703
One-hour and two-hour postload plasma glucose concentrations are comparable predictors of type 2 diabetes mellitus in Southwestern Native Americans Ethan PaddockMaximilian G. HohenadelDouglas C. Chang Article 29 June 2017 Pages: 1704 - 1711
The kynurenine:tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease Eirik W. RebnordElin StrandEva R. Pedersen Article Open access 13 June 2017 Pages: 1712 - 1721
Genetic risk scores in the prediction of plasma glucose, impaired insulin secretion, insulin resistance and incident type 2 diabetes in the METSIM study Alena StančákováTeemu KuulasmaaMarkku Laakso Article 01 June 2017 Pages: 1722 - 1730
The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice Anne ØrgaardJens J. Holst Article Open access 27 May 2017 Pages: 1731 - 1739
Early metabolic markers identify potential targets for the prevention of type 2 diabetes Gopal PeddintiJeff CobbLeif Groop Article Open access 08 June 2017 Pages: 1740 - 1750
Age-dependent insulin resistance in male mice with null deletion of the carcinoembryonic antigen-related cell adhesion molecule 2 gene Simona S. GhanemHarrison T. MuturiSonia M. Najjar Article 31 May 2017 Pages: 1751 - 1760
Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice Shogo IdaKatsutaro MorinoHiroshi Maegawa Article 22 June 2017 Pages: 1761 - 1769
Retinal vascular geometry and 6 year incidence and progression of diabetic retinopathy Carol Yim-lui CheungCharumathi SabanayagamTien Yin Wong Article 16 June 2017 Pages: 1770 - 1781
Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes Nicolae M. PanduruCarol Forsblomon behalf of the FinnDiane Study Group Article 10 June 2017 Pages: 1782 - 1790
High glucose increases the formation and pro-oxidative activity of endothelial microparticles Dylan BurgerMaddison TurnerKevin D. Burns Article 10 June 2017 Pages: 1791 - 1800
The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype Ángela VinuéJorge NavarroHerminia González-Navarro Article 12 June 2017 Pages: 1801 - 1812
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes Pascal BusMarion ScharpfeneckerHans J. Baelde Article Open access 15 June 2017 Pages: 1813 - 1821
Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications Ming ZhuXiao HeXiang Xu Article 03 June 2017 Pages: 1822 - 1833
Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific Ilaria MarzinottoDaniela LiberatiVito Lampasona Research Letter 19 July 2017 Pages: 1834 - 1835